CD105 (Endoglin): A potential anticancer therapeutic inhibits mitogenesis and map kinase pathway activation

Donghui Liu, Shant Kumar, Jason Ashworth, Kamela Ali, Abdulmannan Fadel, Baoqiang Guo, Mark Slevin

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CD105 (Endoglin): A potential anticancer therapeutic inhibits mitogenesis and map kinase pathway activation'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry

Immunology and Microbiology